NMC Royal Khalifa City: A lifeline for women facing placenta accreta spectrum disorder
In June 2023, NMC Royal Hospital, Khalifa City, proudly launched its Placenta Accreta Spectrum Disorder (PASD) programme - a groundbreaking initiative designed to provide world-class care for expectant mothers diagnosed with this high-risk condition. Over the past year, ten women have successfully undergone treatment through this programme, each receiving expert, multidisciplinary care tailored to their unique medical needs.
For women diagnosed with PASD, the journey can be emotionally and physically challenging due to the potential complications involved. PASD occurs when the placenta attaches too deeply into the uterine wall, posing serious risks during childbirth, including severe bleeding and, in many cases, the need for a hysterectomy. At NMC Royal Hospital, Khalifa City, our highly specialised PASD team is transforming the standard approach by offering innovative, patient-centered solutions that prioritise both safety and fertility preservation.
What distinguishes our PASD programme is its personalised and meticulously coordinated treatment protocol. Each patient undergoes a comprehensive evaluation, including MRI confirmation, allowing for detailed pre-operative planning. This ensures every expectant mother receives an individualised care plan specifically tailored to her condition. Our multidisciplinary team collaborates on every PASD case and comprises obstetricians, maternal-fetal medicine specialists, interventional radiologists, urologists, anesthesiologists, intensive care experts, and a highly skilled surgical team.
While hysterectomy is often the standard course of action in many hospitals to manage PASD and prevent life-threatening complications, our advanced PASD protocols, state-of-the-art facilities, and experienced team have changed the narrative. Remarkably, none of the women treated under our PASD programme have required a hysterectomy. Moreover, blood loss was kept to a minimum in all cases, leading to faster recovery times and significantly improved long-term maternal health outcomes. This represents a major breakthrough in PASD treatment - offering women not only hope but also the possibility of preserving their fertility while ensuring the safest possible delivery.
Placenta Accreta Spectrum Disorder is one of the most complex pregnancy-related conditions, and its successful management demands expertise, experience, and a highly integrated team approach tailored to each individual case. Early diagnosis, coupled with meticulous planning, plays a pivotal role in ensuring safer deliveries and better maternal outcomes.
At NMC Royal Hospital, Khalifa City, we are proud to lead the way in PASD care. We remain steadfast in our commitment to driving innovation, setting new benchmarks in women’s health, and providing every woman facing this condition with not only the highest level of medical expertise but also the compassion, reassurance, and support she deserves.
Our dedication to continuous advancement and excellence in maternal-fetal care ensures that every expectant mother who walks through our doors receives the safest, most effective, and most compassionate treatment available today.
